Scientists in the UK are starting trials of a cocktail of antibody drugs that they hope will help treat people with symptoms of COVID-19. The mix, developed by Regeneron Pharmaceuticals, is to be given to people who have the infection and are at high risk. Experts say demand is expected to outstrip supply.
Dr. Rafael Mañez Mendiluce is the Director of the Intensive Care Department at the University Hospital in Barcelona. He says as there are no treatments, any new therapies for COVID-19 patients will be very welcome.
Watch Euronews’ interview with Dr. Rafael Mañez Mendiluce in the media player above.
Related posts:
China using big data to detain people before crime is committed: report
God Develops Ultra-Realistic Metaverse Where People Can Talk, Learn, And Work With Other People, Cal...
India becomes COVID-19 second-worst-hit nation with 90,000 cases in 24 hours
Kent Christmas Claims ‘Evil People’ Took His Shocking Sermon ‘Out of Context’...
Andrea Mitchell: Trump's Sanctions and COVID 'Cratered' Cuba's Economy
Ex-Obama Econ. Adviser Furman: People Have Poor View of Economy Because They're in a Hole Due to Inf...